<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://regional.gourt.com/North-America/United-States/Government/Executive-Branch/Departments/Department-of-Health-and-Human-Services/Food-and-Drug-Administration.xml">
<title>Food_and_Drug_Administration RSS : Gourt</title>
<link>http://regional.gourt.com/North-America/United-States/Government/Executive-Branch/Departments/Department-of-Health-and-Human-Services/Food-and-Drug-Administration.xml</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-06T20:41+01:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Food_and_Drug_Administration RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189436.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189311.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189295.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189081.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189394.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188750.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188748.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188717.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188715.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188708.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188543.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188768.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188776.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188374.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188305.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188266.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187966.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187813.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187174.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm189402.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm189296.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188981.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188971.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188954.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188912.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188929.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188578.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188570.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188628.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188562.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188321.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188521.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188318.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188156.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm188137.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm187979.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm187973.htm" />
  <rdf:li rdf:resource="http://www.fda.gov/Safety/Recalls/ucm187949.htm" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189436.htm">
<title>FDA Warns Companies against Marketing Illegal Flavored Cigarettes</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189436.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration is enforcing the flavored cigarette ban provision of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) by issuing several warning letters to companies continuing to sell illegal flavored cigarettes to consumers in the United States through their Web sites.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm">
<title>FDA  Health Alert for Certain Pet Treats Made by Pet Carousel</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration is issuing this health alert to warn consumers not to use Pig Ears and Beef Hooves pet treats manufactured by Pet Carousel because the products may be contaminated with Salmonella. The products were distributed nationwide in both bulk and retail packaging for sale in pet food and retail chain stores. Pet Carousel is based in Sanger, Calif.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189311.htm">
<title>FDA and FSIS Collaborate To Improve Tracing of Unsafe Food Products</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189311.htm</link>
<description><![CDATA[A joint public meeting focused on improving the system for tracing of food products and ingredients that are causing illness outbreaks or presenting other risks to the health of consumers was announced today by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services and the Food Safety and Inspection Service (FSIS) of the U.S. Department of Agriculture (USDA).]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189295.htm">
<title>FDA Warns Consumers on Sexual Enhancement Products</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189295.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189081.htm">
<title>FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication Use</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189081.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today announced the Safe Use Initiative, a program aimed at reducing the likelihood of preventable harm from medication use.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189394.htm">
<title>U.S. Attorney News Release: Doctor Sentenced for Writing Prescriptions Over the Internet for People Whom He Had Never Met or Examined</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189394.htm</link>
<description><![CDATA[A Virginia doctor was sentenced in federal court on charges that he wrote prescriptions over the Internet for people whom he had never met or examined, as well as tax evasion.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188750.htm">
<title>FDA, JIFSAN Travel to Bangladesh to Teach Seafood Safety</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188750.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration and the Joint Institute for Food Safety and Applied Nutrition (JIFSAN) have sent a team of seafood specialists to Bangladesh this week to help train local officials on aquaculture safety and quality control techniques.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188748.htm">
<title>FDA Consumer  Health Information  Updates</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188748.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration (FDA) today released a listing of eight recent consumer health information updates concerning the safety of FDA-regulated products.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188717.htm">
<title>FDA Publishes Guidance on Diagnostic Tests for 2009 H1N1 Influenza Virus</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188717.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today published a guidance document that should help manufacturers develop diagnostic tests for the 2009 H1N1 influenza virus. Although there are not any FDA-approved or cleared tests that diagnose this specific infection, during this pandemic, manufacturers can submit a request to the FDA for an Emergency Use Authorization (EUA). If granted, the EUA will allow the test to be used during the national public health emergency declared by Department of Health and Human Services Secretary Kathleen Sibelius in April. This guidance document outlines what information the FDA recommends that manufacturers include in these EUA requests.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188715.htm">
<title>FDA Transparency  Task Force to Hold 2nd Public Meeting on Ensuring That Agency Information is Useful, Understandable, Accessible</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188715.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration will seek comments on three specific issues related to transparency at the agency during a daylong public meeting on Tuesday, Nov. 3, 2009.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188708.htm">
<title>FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188708.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188543.htm">
<title>FDA: Procter &#x26; Gamble Unlawfully Marketing Two Vicks Cold and Flu Medicines Containing Vitamin C</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188543.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients and a dietary ingredient.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188768.htm">
<title>U.S. Attorney News Release: Bellevue Salon Owner Convicted in Connection With Unlicenced Cosmetic Treatments</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188768.htm</link>
<description><![CDATA[XIN HE, aka FAITH HE, 46, of Issaquah, Washington, was found guilty today in U.S. District Court in Seattle of a felony count of Misbranding of a Drug While Held for Sale and two misdemeanor counts of Receipt & Proffered Delivery of Adulterated Device. HE was ordered into immediate custody by U.S. District Judge Marsha J. Pechman after she rendered her verdict.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188776.htm">
<title>U.S. Attorney News Release: Boca Raton Man Convicted in Nutritional Supplement Scam</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188776.htm</link>
<description><![CDATA[Jeffrey H. Sloman, Acting United States Attorney for the Southern District of Florida, David Bourne, Special Agent in Charge, Food and Drug Administration, Office of Criminal Investigations, Daniel W. Auer, Special Agent in Charge, Internal Revenue Service, Criminal Investigation Division, and Henry Gutierrez, Postal Inspector in Charge, U.S. Postal Inspection Service, announce that late yesterday afternoon, a federal jury convicted defendant Frank Sarcona, a/k/a Frank Sarcone, a/k/a Dave Johnson, 57, of Boca Raton, FL, of conspiracy to commit mail, wire fraud, and criminal contempt of court; conspiracy to commit money laundering; and multiple counts of substantive mail fraud, wire fraud, money laundering, misbranding of a food, and criminal contempt of court. Sentencing has been scheduled for January 15, 2010 at 9:00 a.m. before U.S. District Court Judge Kenneth A. Marra.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188374.htm">
<title>FDA and WebMD Expand Consumer Health Information Partnership</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188374.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration and WebMD Health Corp. today announced an expansion of their partnership to provide increased access to FDA’s consumer health information. This second phase of the partnership includes expanded content and multimedia tools at www.webmd.com/fda. WebMD is personalizing FDA health information for consumers with five new online FDA sections that will initially focus on allergies and asthma, children’s health, diabetes, heart health and vitamins and supplements.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188305.htm">
<title>U.S. Attorney News Release: Stryker Biotech and Its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188305.htm</link>
<description><![CDATA[Stryker Biotech, LLC, a corporation based in Hopkinton, Massachusetts, and its former president, Mark Philip of Lexington, Massachusetts, and its current sales managers, William Heppner of Illinios, David Ard of California, and Jeff Whitaker of North Carolina, were charged today in federal court with participating in a fraudulent marketing scheme of medical devices used during invasive spinal and long bone surgeries. Stryker Biotech and Mark Philip were also charged with making false statements to the United States Food and Drug Administration (“FDA”).]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188266.htm">
<title>Registration Closes Soon for FDA&#x2019;s Second Annual Science Writers Symposium</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm188266.htm</link>
<description><![CDATA[A few spaces remain for the U.S. Food and Drug Administration’s Second Annual Science Writers Symposium on Nov. 4-5, 2009.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187966.htm">
<title>FDA Approves New Treatment for Chronic Lymphocytic Leukemia</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187966.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187813.htm">
<title>FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187813.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187174.htm">
<title>FDA Approves New Treatment for Advanced Form of Kidney Cancer</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187174.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm189402.htm">
<title>Jelly Belly Issues Allergy Alert on Undeclared Peanuts in 7.5oz cylinder-style packages of 49 Flavors Jelly Belly jelly beans</title>
<link>http://www.fda.gov/Safety/Recalls/ucm189402.htm</link>
<description><![CDATA[Jelly Belly Candy Company is recalling 7.5-ounce cylinder-style packages of 49 Flavors Jelly Belly jelly beans because the package is incorrectly labeled. The mislabeled packages failed to list peanut butter and peanut flour in the ingredient statement...]]></description>
</item>

<item rdf:about="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm">
<title>FDA  Health Alert for Certain Pet Treats Made by Pet Carousel</title>
<link>http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm189400.htm</link>
<description><![CDATA[The U.S. Food and Drug Administration is issuing this health alert to warn consumers not to use Pig Ears and Beef Hooves pet treats manufactured by Pet Carousel because the products may be contaminated with Salmonella. The products were distributed nationwide in both bulk and retail packaging for sale in pet food and retail chain stores. Pet Carousel is based in Sanger, Calif.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm189296.htm">
<title>PetSmart Voluntarily Recalls Dentley&#x2019;s Beef Hooves</title>
<link>http://www.fda.gov/Safety/Recalls/ucm189296.htm</link>
<description><![CDATA[PetSmart (NASDAQ: PETM) is voluntarily recalling two Dentley’s Beef Hoof products for potential salmonella contamination. The products were manufactured by Pet Carousel, Inc. in Sanger, Calif.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188981.htm">
<title>Centurion Medical Products - Premie Pack and Meconium Pack - Recall</title>
<link>http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188981.htm</link>
<description><![CDATA[Kits recalled because the pediatric tracheal tubes were manufactured with an internal diameter smaller than indicated on the label.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188971.htm">
<title>Charleston Cookie Company Issues Allergy Alert on Undeclared Butter in Almond Cookies Produced for Dean &#x26; Deluca</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188971.htm</link>
<description><![CDATA[Charleston Cookie Company of Charleston, SC is recalling packages of Almond Cookies which were sold as a component of the Dean and Deluca "Americana" cookie tin because the cookies contain undeclared butter (milk).]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188954.htm">
<title>American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188954.htm</link>
<description><![CDATA[American Regent conducts nationwide voluntary recall of  ALL lots of its Ketorolac Tromethamine Injection, USP 15 mg/mL:
         NDC# 0517-0601-25     15 mg/mL       1mL Single Dose Vial
PLEASE NOTE:  This recall is in addition to the voluntary recall initiated on October 16, 2009 when American Regent voluntarily recalled ALL unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL due to the presence of particulate matter in conjunction with crystallization.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188912.htm">
<title>Pelican Bay Ltd. Issues Nationwide Allergy Alert on Undeclared Tree Nuts in Caramel Chocolate Truffle Hot Chocolate Mix</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188912.htm</link>
<description><![CDATA[Pelican Bay Ltd. of Dunedin, Florida is recalling all their Caramel Chocolate Truffle Hot Chocolate Mix because it may contain undeclared tree nuts.  People who have an allergy or severe sensitivity to tree nuts run the risk of serious or life-threatening allergic reaction if they consume these products.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188929.htm">
<title>BODYBUILDING.COM Is Conducting a Voluntary Nationwide and International Recall of 65 Dietary Supplements That May Contain Steroids</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188929.htm</link>
<description><![CDATA[As part of its ongoing
cooperation with the Food and Drug Administration (“FDA”), Bodybuilding.com, LLC (the
“Company”) announced today that it is conducting a voluntary nationwide and international
recall of all lots and expiration dates of 65 dietary supplement products (the “Recalled Products”)
described on the attached list, that were sold through the Company’s website,
www.bodybuilding.com.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188578.htm">
<title>Allergy Alert on Possible  Undeclared Soy Protein in32-ounce Great Value Half &#x26;amp;  Half, 32-ounce Great Value 36% Heavy Whipping Cream, 32-ounce Kroger brand 36% Heavy  Whipping Cream, and 64-ounce Wholesome Farms Chocolate Ice Cream Mix</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188578.htm</link>
<description><![CDATA[Morningstar Foods is voluntarily recalling 32-ounce Great Value Half & Half, UPC  6 05388 187 16 1, item code 1871600, plant code 21-031; 32-ounce Great Value 36% Heavy Whipping Cream, UPC  6 05388 187 18 5, item code 1871800, plant code 21-031; 32-ounce Kroger brand 36% Heavy Whipping Cream, UPC  0 11110 438 28 7, item code 4382900, plant code 21-031; and 64-ounce Wholesome Farms Chocolate Ice Cream Mix, UPC  0 74865 57 983 4 (if purchased in a multi-pack, the UPC code is 1 00 74865 57983 1), item code 5798300, plant code 21-031 because these products may contain soy protein.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188570.htm">
<title>Alexia Foods issues nationwide allergy alert and product recall on its Alexia Olive Oil, Sun-Dried Tomatoes &#x26; Pesto Oven Reds frozen potatoes due to undeclared pine nut allergen</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188570.htm</link>
<description><![CDATA[Today, Alexia Foods, Inc, Kennewick, WA, in cooperation with the U.S. Food and Drug Administration (FDA) is voluntarily recalling packages of its Alexia – Olive Oil, Sun-Dried Tomatoes & Pesto Oven Reds (frozen seasoned potato wedges) for an undeclared allergen, pine nuts. People who have an allergy or severe sensitivity to pine nuts run the risk of serious or life-threatening allergic reaction if they consume these products.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188628.htm">
<title>Pointe Scientific, Inc Expands Nationwide Recall of Liquid Glucose Hexokinase Reagent (G7517)</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188628.htm</link>
<description><![CDATA[Pointe Scientific, Inc, Canton, MI is initiating a nationwide recall of all size kits of Liquid Glucose Hexokinase Reagent catalog number G7517.  The reagents have been found to fail linearity at >200mg/dL that results in inaccurate glucose values above this range.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188562.htm">
<title>Pointe Scientific Liquid Glucose Hexokinase Reagent  - Recall</title>
<link>http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188562.htm</link>
<description><![CDATA[Nationwide recall of all size kits. The reagents have been found to fail linearity at >200mg/dL that results in inaccurate glucose values above this range.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188321.htm">
<title>Cordis Initiates Nationwide Recall of CROSSOVER&#x2122; Sheath Introducer</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188321.htm</link>
<description><![CDATA[Cordis Corporation announced today a nationwide voluntary recall of all lots of the CROSSOVER™ Sheath Introducer due to complaints about stretching or fracture of the sheath during use.  

 

The CROSSOVER™ Sheath Introducer is a product developed and manufactured by Thomas Medical Products, Inc., and distributed by Cordis.  It is a long-coil reinforced, kink-resistant catheter sheath intended for use in arterial and venous procedures requiring the percutaneous, or through the skin, introduction of therapeutic or diagnostic intravascular devices or fluids]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188521.htm">
<title>Pointe Scientific, Inc Issues Nationwide Recall of Liquid Glucose Hexokinase Reagent (G7517)</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188521.htm</link>
<description><![CDATA[Pointe Scientific, Inc, Canton, MI is initiating a nationwide recall of all size kits of  Liquid Glucose Hexokinase Reagent catalog number G7517.  The reagents have been found to fail linearity at >200mg/dL that results in inaccurate glucose values above this range.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188318.htm">
<title>Mrs. Rios Corn Products Issues Allergy Alert on Undeclared Whey in Flour Tortillas</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188318.htm</link>
<description><![CDATA[Mrs. Rios Corn Products in San Angelo, Texas is recalling its flour tortillas because they may contain undeclared Whey.  People who have an allergy or severe sensitivity to Whey run the risk of serious or life-threatening allergic reaction if they consume these products.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188156.htm">
<title>Pop&#x2019;s Bakery Inc. Issues Allergy on Undeclared Whey (Milk) in all Flour Tortillas</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188156.htm</link>
<description><![CDATA[These products may contain undeclared whey (milk). People who have an allergy or severe sensitivity to whey (milk) run the risk of serious or life-threatening allergic reaction if they consume these products.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm188137.htm">
<title>Qualitest Pharmaceuticals Issues a Voluntary Nationwide Recall of All Accusure&#xAE; Insulin Syringes</title>
<link>http://www.fda.gov/Safety/Recalls/ucm188137.htm</link>
<description><![CDATA[Huntsville AL-Qualitest Pharmaceuticals today issued a voluntary nationwide recall of all Accusure® Insulin Syringes. The distributed syringes are of the following descriptions and NDC numbers: 28G 1/2cc, NDC 0603-6995-21;28G 1cc, NDC 0603-6996-21; 29G 1/2cc NDC 0603-6997-21, 29G 1cc, NDC 0603-6998-21, 30G 1/2cc, NDC 0603-999-21, 30G 1cc, NDC 0603-7000-21, 31G 1/2cc, NDC 0603-7001-21, 31G 1cc, NDC 0603-7002-21. All Accusure® Insulin Syringes regardless of lot number are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico). The syringes in these lots may have needles which detach from the syringe.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm187979.htm">
<title>San Link Inc. Issues an Alert on Uneviscerated Vacuum Pack Dried Lesh (Fish).</title>
<link>http://www.fda.gov/Safety/Recalls/ucm187979.htm</link>
<description><![CDATA[San Link Inc at 54B Marjorie Street Staten Island, NY 10309 is recalling Vacuum Pack Dried Lesh (fish) because the product was found to be uneviscerated.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm187973.htm">
<title>San Link Inc. Issues an Alert on Uneviscerated Vacuum Pack Dried Krasnoperka (Fish).</title>
<link>http://www.fda.gov/Safety/Recalls/ucm187973.htm</link>
<description><![CDATA[San Link Inc at 54B Marjorie Street Staten Island, NY 10309 is recalling Vacuum Pack Dried Krasnoperka (fish) because the product was found to be uneviscerated.]]></description>
</item>

<item rdf:about="http://www.fda.gov/Safety/Recalls/ucm187949.htm">
<title>Mars Snackfood US ISSUES ALLERGY ALERT ON UNDECLARED PEANUTS In Dove Caramel Pecan Perfection Ice Cream</title>
<link>http://www.fda.gov/Safety/Recalls/ucm187949.htm</link>
<description><![CDATA[Today, Mars Snackfood US announced a voluntary recall of its Dove Caramel Pecan Perfection ice cream with the lot number 931AB5YN07 because it may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products. No related illnesses have been reported to date.]]></description>
</item>

</rdf:RDF>